EQRx

Closed

Remaking Medicine™

Cambridge, United States · Founded 2019 · $700.0M raised

Employees
51–200
Founded
2019
Business Model
B2B
Website
eqrx.com
Total Funding
$700.0M
Last Round
$500.0M Series BJan 2021
Rounds
2

About

EQRx was a biopharmaceutical company founded in 2019 committed to developing innovative, patent-protected medicines and delivering them at dramatically lower prices than traditional pharmaceutical companies. The company built a pipeline of 10+ programs including Phase 3 oncology assets for non-small cell lung cancer, raised over $750 million in funding, and was acquired by Revolution Medicines in November 2023.

Summary

EQRx is a Healthcare company based in Cambridge, United States, founded in 2019. It has raised $700.0M in total across 2 rounds, most recently a $500.0M Series B round in Jan 2021. Investors include Andreessen Horowitz, GV and ARCH Venture Partners.

Tech & App Stack

2 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Sign up to view the funding chart

Create a free account with 25 free credits every month, no card needed, to unlock funding history, valuations, and tech stacks.

AcquisitionAug 2023

Sign up to see all 4 rounds

Series A through Acquisition — per-round amounts, valuations, and who invested in each round.

Investors

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

EQRx on Indexed.vc
<a href="https://indexed.vc/companies/eqrx"><img src="https://indexed.vc/api/badge/company/eqrx" alt="EQRx on Indexed.vc" width="260" height="76" /></a>